Present results and future perspectives in optimizing chronic myeloid leukemia therapy

被引：6
|
作者：
Carella, Angelo M. [1 ]
Saglio, Giuseppe [2 ,3 ]
Mahon, Xavier F. [4 ]
Mauro, Michael J. [5 ]
机构：
[1] Osped Policlin San Martino, Hematol & BMT Unit, Genoa, Italy
[2] Univ Torino, Dipartimento Sci Clin & Biol, Turin, Italy
[3] Osped Mauriziano Torino, Turin, Italy
[4] Univ Bordeaux, Bergonie Canc Inst, Bordeaux, France
[5] Mem Sloan Kettering Canc Ctr, Myeloproliferat Neoplasms Program, 1275 York Ave, New York, NY 10021 USA
来源：
HAEMATOLOGICA | 2018年 / 103卷 / 06期
关键词：
TYROSINE KINASE INHIBITOR; COMPLETE MOLECULAR REMISSION; CHRONIC MYELOGENOUS LEUKEMIA; CHRONIC-PHASE; IMATINIB TREATMENT; FOLLOW-UP; DISCONTINUATION; DASATINIB; CML; IMPACT;
D O I：
10.3324/haematol.2017.182022
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：928 / 930
页数：3
相关论文
共 50 条
  • [1] Optimizing therapy of chronic myeloid leukemia
    Deininger, Michael W. N.
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (04) : 144 - 154
  • [2] Optimizing second-line therapy for chronic myeloid leukemia
    Raja, T.
    INDIAN JOURNAL OF CANCER, 2012, 49 (01) : 46 - 56
  • [3] First-line therapy for chronic myeloid leukemia: past, present, and future
    Pavlovsky, Carolina
    Kantarjian, Hagop
    Cortes, Jorge E.
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (05) : 287 - 293
  • [4] Molecular monitoring of chronic myeloid leukemia: present and future
    Yeung, Cecilia Ching Sze
    Egan, Daniel
    Radich, Jerald P.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2016, 16 (10) : 1083 - 1091
  • [5] Chronic Myeloid Leukemia Prognosis and Therapy: Criticisms and Perspectives
    Russo, Domenico
    Garcia-Gutierrez, Jose Valentin
    Soverini, Simona
    Baccarani, Michele
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06)
  • [6] Debating Frontline Therapy in Chronic Myeloid Leukemia
    Bi, Xia
    Ramanathan, Sabarina
    Keiffer, Gina
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [7] Chronic Myeloid Leukemia: State of the Art in 2012
    Fava, Carmen
    Rege-Cambrin, Giovanna
    Saglio, Giuseppe
    CURRENT ONCOLOGY REPORTS, 2012, 14 (05) : 379 - 386
  • [8] Optimizing Therapy for Patients With Chronic Myelogenous Leukemia in Chronic Phase
    Kantarjian, Hagop M.
    Cortes, Jorge
    La Rosee, Paul
    Hochhaus, Andreas
    CANCER, 2010, 116 (06) : 1419 - 1430
  • [9] Dose optimization of tyrosine kinase inhibitor therapy in chronic myeloid leukemia
    Umezawa, Yoshihiro
    Sasaki, Koji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 117 (01) : 24 - 29
  • [10] Chronic Myeloid Leukemia in 2020
    Hehlmann, Ruediger
    HEMASPHERE, 2020, 4 (05): : E468
12345